Glutathione Injections in Dubai

A glutathione drip is an intravenous infusion of glutathione, an antioxidant the body produces naturally in the liver. It is administered over 30–60 minutes, usually at 600–2,000 mg per session, and is often combined with vitamin C. In the UAE it is used off-label for skin brightening, and on-label for specific medical indications.

Glutathione's registered pharmaceutical form (ATC code V03AB32) is classified as an antidote. Its licensed indications include use as an adjunct in cisplatin-based chemotherapy, in certain intoxications, and in hepatopathy. Skin lightening is not a registered indication anywhere.

That distinction matters, and no other Dubai clinic page states it: cosmetic use of IV glutathione is off-label use. Off-label prescribing is legal and routine in medicine, but it means the product has not been assessed by a regulator for this purpose, and you should be told that before you consent.

Evidence for intravenous glutathione as a skin-lightening treatment is weak. The only placebo-controlled trial identified in a 2025 systematic review found no statistically significant difference from placebo (37.5% vs 18.7%, p = 0.054). Oral glutathione at 250–500 mg daily and topical 0.5% glutathione both showed significant melanin-index reduction versus placebo across five randomised controlled trials.

Evidence by route of administration

A 2018 review of the IV literature concluded the evidence rested on a single study with a questionable design and flawed analysis. A 2025 narrative review reached the same position, adding that IV administration carries safety concerns including anaphylaxis and hepatotoxicity compounded by the absence of any standardised dosing protocol.

The 2025 International Journal of Dermatology systematic review states its conclusion directly: IV glutathione is contraindicated for cosmetic lightening on grounds of both efficacy and safety.

What that does not mean

It does not mean patients report nothing. A 2026 safety analysis of 93 healthy female participants found roughly one-third (34 of 93) noticed mild-to-moderate skin whitening over a 10-week course. That is a real observation. It is also uncontrolled, short-duration, and does not establish that the effect exceeds placebo.

The honest summary: some people notice a change. The trials have not shown that the change is reliably attributable to the drip.

Regulators including the US FDA and the FDA Philippines have issued public warnings on injectable skin-lightening agents. Documented and warned-about risks include severe cutaneous reactions such as Stevens-Johnson syndrome, hepatic and renal injury, thyroid disturbance, anaphylaxis, endotoxin contamination from non-pharmaceutical-grade product, and bloodborne infection transmission where sterile technique is not maintained.

Regulatory position

• The US FDA published guidance in April 2018 stating that injectable skin-lightening and skin-bleaching products may be unsafe, and has separately warned compounders against using dietary-supplement-grade glutathione to prepare sterile injectables following adverse events linked to endotoxin contamination.
• FDA Philippines Advisory No. 2019-182 warns the public on injectable glutathione for skin lightening, citing toxicity to liver, kidneys and nervous system, the possibility of Stevens-Johnson syndrome, infection transmission risk including HIV and hepatitis B and C, and a theoretical long-term skin cancer concern arising from reduced melanin.
• No regulator has approved any injectable product for skin lightening.

Case literature

A 2025 case report describes systemic inflammatory response syndrome in a previously healthy woman in her thirties who collapsed within an hour of receiving a high-dose unregulated glutathione infusion for skin lightening. She presented with hyperpyrexia above 41°C, white cell count 26 × 10⁹/L, CRP 160 mg/L, ALT 311 IU/L and coagulopathy. She had been self-administering tirzepatide with substantially reduced dietary intake. She recovered fully with supportive care.

That case is directly relevant to Dubai's patient population, where GLP-1 receptor agonist use for weight management is widespread and often accompanied by low nutritional intake. Ask any clinic whether they screen for this. Most do not.

At Halcyon Aesthetics Dubai, our clinical team does not administer high-dose antioxidant infusions without baseline assessment. Our standard pre-treatment workup includes:

Our practitioners also confirm product provenance. We use only pharmaceutical-grade, MOHAP-registered preparations with batch traceability — never compounded or supplement-grade glutathione, which is the source of the endotoxin contamination events flagged by the US FDA.

Glutathione drips in Dubai typically range from AED 250 to AED 1,400 per session depending on dose, additional actives, and whether treatment is in-clinic or at-home. Multi-session packages reduce per-session cost. A 5% VAT applies to all IV therapy in the UAE.

What the advertised price usually excludes: doctor consultation, screening bloods (including G6PD), and follow-up review. At [CLINIC NAME] our quoted price is [inclusive / exclusive] of consultation and baseline screening — we state this before you book, not after.

• Before Consultation, medical history, screening bloods, informed consent covering off-label status. Eat normally and hydrate beforehand — reduced nutritional intake is a documented risk factor.
• During Cannulation, then infusion over 30–60 minutes under supervision. You remain monitored throughout. A fine-gauge cannula reduces discomfort at insertion.
• Immediately after 15–30 minutes observation for delayed reaction. No downtime; most people resume normal activity the same day.
• Following days Mild transient effects can include headache, nausea, a metallic taste, or bruising at the cannula site. Contact us immediately if you develop rash, fever, breathing difficulty, dark urine, or jaundice.
• Ongoing Any pigment effect is not permanent and reverses when treatment stops. Daily broad-spectrum SPF is mandatory this matters more if melanin has been reduced.